In these studies, lentivirus was used to deliver Cre-recombinase to drive the expression of KRAS[Gly12Asp] whilst simultaneously delivering CRISPR guides to disrupt SIK1 and SIK3 expression, which accelerated tumour growth. The gene discussed is SIK1; the disease is neoplasm.